We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Descovy

News List

PrEP HIV Prevention Pills to Be Free for Insured Americans drugs
July 22, 2021
Nearly all health insurers must cover the entire cost of HIV prevention treatments, the U.S. government says. That includes the two approved pre-exposure prophylaxis(PrEP) drugs Truvada and Descovy, all clinic visits, and lab tests, NBC News reported.
Gilead's $3B Truvada will face generics a year early. Can Descovy still win over its patients? fiercepharma
May 12, 2019
For years, Gilead Sciences has said its antiviral drug Truvada, used to treat and prevent HIV infection, wouldn’t face generic competition until 2021. But Gilead recently—and quietly—moved its generic expectations up a year.